Teneligliptin

CAS : 760937-92-6

Ref. 3D-FT150538

Informations sur le produit

• Nom: Teneligliptin
• Synonymes: 3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]thiazolidine, Methanone, [(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-, Tenelia, Thiazolidine, 3-[[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-, [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone
• CAS: 760937-92-6

Description

Teneligliptin is a selective inhibitor of the P-glycoprotein (P-gp) transporter and is used for the treatment of type 2 diabetes. Teneligliptin has been shown to reduce postprandial blood glucose levels by inhibiting DPP-IV, which is an enzyme that degrades glucagon-like peptide 1 (GLP-1). It also inhibits the activity of dpp-4, which is an enzyme that inactivates GLP-1. The combination therapy group had significantly lower HbA1c levels than the control analysis group in a study of teneligliptin and metformin. Teneligliptin has also been shown to have a long half life and low risk of drug interactions in human pharmacokinetic studies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 426.58 g/mol
• Formule: C₂₂H₃₀N₆OS
• Degré de pureté: Min. 95%